Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endonovo Therapeutics Inc (OTCQB:ENDV.PK)

0.5255
Delayed Data
As of Feb 05
 -0.0745 / -12.42%
Today’s Change
0.05
Today|||52-Week Range
1.10
+45.93%
Year-to-Date
No recent news for Endonovo Therapeutics Inc.

Today’s Trading

Previous close0.60
Today’s open0.60
Day’s range0.50 - 0.60
Volume105,846
Average volume (3 months)82,154
Market cap$53.2M
Dividend yield--
Data as of 3:47pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+99.25%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+5.66%
P/E ratioNM
Price/Sales1,564.98
Price/Book--

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$24.2K
Annual profit (last year)-$959.5K
Net profit margin-3,966.16%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, CEO, CFO &
Secretary
Alan Brian Collier
President &
Executive VP-Shareholder Relations
Michael Scott Mann
Corporate headquarters
Woodland Hills, California

Forecasts

Partner Offers